Literature DB >> 30810840

Novel Heterogeneous Mutation of TNFAIP3 in a Chinese Patient with Behçet-Like Phenotype and Persistent EBV Viremia.

Xiaolong Dong1, Luyao Liu1, Ying Wang1, Xiaotao Yang2, Wenjie Wang1, Li Lin1, Bijun Sun1, Jia Hou1, Wenjing Ying1, Xiaoying Hui1, Qinhua Zhou1, Danru Liu1, Haili Yao1, Jinqiao Sun3, Xiaochuan Wang4.   

Abstract

PURPOSE: Tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20) is a negative regulator of the nuclear factor-κB (NF-κB) pathway. It has recently been recognized that TNFAIP3 deficiency leads to early onset of autoinflammatory and autoimmune syndrome resembling Behçet's disease. Here, we report a novel mutation in TNFAIP3 in a Chinese patient, who had Behçet-like phenotype and persistent Epstein-Barr virus (EBV) viremia.
METHODS: The clinical data were collected. Immunological function was detected. Gene mutation was detected by whole-exome sequencing (WES) and confirmed by Sanger sequencing. mRNA and protein levels were detected in the patient under lipopolysaccharide (LPS) stimulation by real-time PCR and Western blot.
RESULTS: The patient is a 13-year-old boy, presenting with intermittent fever for 5 months, who also experienced diffuse lymphadenopathy, arthritis, and recurrent multiple gastrointestinal ulcers. EBV DNA was detected in the serum and peripheral blood mononuclear cells of the patient. The immunological phenotype showed increased proportion of double-negative T cells (CD3+CD4-CD8-). A novel missense mutation (c.1428G > A) locating at the zinc fingers 2 (ZF2) domain of TNFAIP3 inherited from his mother was confirmed. Compared with age-matched healthy controls, decrease expression of A20 was observed in the patient. The NF-κB pathway was found to be overactivated, and the synthesis of TNF-α was upregulated in the patient-derived cells. However, cells from the mother showed a milder response to LPS than cells from the patient.
CONCLUSIONS: The present research indicated that the TNFAIP3 mutation of c.1428G > A (p.M476I) leads to the reduced suppression of NF-κB activation and accounted for the autoinflammatory phenotype and persistent EBV viremia in the patient.

Entities:  

Keywords:  EBV viremia; NF-κB; TNFAIP3; autoinflammatory

Year:  2019        PMID: 30810840     DOI: 10.1007/s10875-019-00604-9

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  33 in total

Review 1.  A20: linking a complex regulator of ubiquitylation to immunity and human disease.

Authors:  Averil Ma; Barbara A Malynn
Journal:  Nat Rev Immunol       Date:  2012-10-12       Impact factor: 53.106

2.  Haploinsufficiency of TNFAIP3 (A20) by germline mutation is involved in autoimmune lymphoproliferative syndrome.

Authors:  Masatoshi Takagi; Shohei Ogata; Hiroo Ueno; Kenichi Yoshida; Tzuwen Yeh; Akihiro Hoshino; Jinhua Piao; Motoy Yamashita; Mai Nanya; Tsubasa Okano; Michiko Kajiwara; Hirokazu Kanegane; Hideki Muramatsu; Yusuke Okuno; Yuichi Shiraishi; Kenichi Chiba; Hiroko Tanaka; Yuki Bando; Motohiro Kato; Yasuhide Hayashi; Satoru Miyano; Kohsuke Imai; Seishi Ogawa; Seiji Kojima; Tomohiro Morio
Journal:  J Allergy Clin Immunol       Date:  2016-11-12       Impact factor: 10.793

3.  A20 zinc finger protein inhibits TNF and IL-1 signaling.

Authors:  M Jäättelä; H Mouritzen; F Elling; L Bastholm
Journal:  J Immunol       Date:  1996-02-01       Impact factor: 5.422

4.  Overlapping genetic susceptibility variants between three autoimmune disorders: rheumatoid arthritis, type 1 diabetes and coeliac disease.

Authors:  Stephen Eyre; Anne Hinks; John Bowes; Edward Flynn; Paul Martin; Anthony G Wilson; Ann W Morgan; Paul Emery; Sophia Steer; Lynne J Hocking; David M Reid; Pille Harrison; Paul Wordsworth; Wendy Thomson; Jane Worthington; Anne Barton
Journal:  Arthritis Res Ther       Date:  2010-09-20       Impact factor: 5.156

5.  The ubiquitin-editing enzyme A20 restricts nucleotide-binding oligomerization domain containing 2-triggered signals.

Authors:  Osamu Hitotsumatsu; Regina-Celeste Ahmad; Rita Tavares; Min Wang; Dana Philpott; Emre E Turer; Bettina L Lee; Nataliya Shiffin; Rommel Advincula; Barbara A Malynn; Catherine Werts; Averil Ma
Journal:  Immunity       Date:  2008-03       Impact factor: 31.745

6.  Frequent inactivation of A20 in B-cell lymphomas.

Authors:  Motohiro Kato; Masashi Sanada; Itaru Kato; Yasuharu Sato; Junko Takita; Kengo Takeuchi; Akira Niwa; Yuyan Chen; Kumi Nakazaki; Junko Nomoto; Yoshitaka Asakura; Satsuki Muto; Azusa Tamura; Mitsuru Iio; Yoshiki Akatsuka; Yasuhide Hayashi; Hiraku Mori; Takashi Igarashi; Mineo Kurokawa; Shigeru Chiba; Shigeo Mori; Yuichi Ishikawa; Koji Okamoto; Kensei Tobinai; Hitoshi Nakagama; Tatsutoshi Nakahata; Tadashi Yoshino; Yukio Kobayashi; Seishi Ogawa
Journal:  Nature       Date:  2009-05-03       Impact factor: 49.962

7.  A20 (TNFAIP3) deletion in Epstein-Barr virus-associated lymphoproliferative disorders/lymphomas.

Authors:  Midori Ando; Yasuharu Sato; Katsuyoshi Takata; Junko Nomoto; Shigeo Nakamura; Koichi Ohshima; Tamotsu Takeuchi; Yorihisa Orita; Yukio Kobayashi; Tadashi Yoshino
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

8.  Novel heterozygous C243Y A20/TNFAIP3 gene mutation is responsible for chronic inflammation in autosomal-dominant Behçet's disease.

Authors:  Tomonari Shigemura; Naoe Kaneko; Norimoto Kobayashi; Keiko Kobayashi; Yusuke Takeuchi; Naoko Nakano; Junya Masumoto; Kazunaga Agematsu
Journal:  RMD Open       Date:  2016-05-05

9.  Analysis of 17 autoimmune disease-associated variants in type 1 diabetes identifies 6q23/TNFAIP3 as a susceptibility locus.

Authors:  E Y M G Fung; D J Smyth; J M M Howson; J D Cooper; N M Walker; H Stevens; L S Wicker; J A Todd
Journal:  Genes Immun       Date:  2008-12-25       Impact factor: 2.676

10.  Deletion of the TNFAIP3/A20 gene detected by FICTION analysis in classical Hodgkin lymphoma.

Authors:  Junko Nomoto; Nobuhiro Hiramoto; Motohiro Kato; Masashi Sanada; Akiko Miyagi Maeshima; Hirokazu Taniguchi; Fumie Hosoda; Yoshitaka Asakura; Wataru Munakata; Naohiro Sekiguchi; Dai Maruyama; Takashi Watanabe; Hitoshi Nakagama; Kengo Takeuchi; Kensei Tobinai; Seishi Ogawa; Yukio Kobayashi
Journal:  BMC Cancer       Date:  2012-10-05       Impact factor: 4.430

View more
  5 in total

1.  The clinical, immunological and genetic features of 12 Chinese patients with STAT3 mutations.

Authors:  Li Lin; Ying Wang; Bijun Sun; Luyao Liu; Wenjing Ying; Wenjie Wang; Qinhua Zhou; Jia Hou; Haili Yao; Liyuan Hu; Jinqiao Sun; Xiaochuan Wang
Journal:  Allergy Asthma Clin Immunol       Date:  2020-07-22       Impact factor: 3.406

2.  Functional analysis of novel A20 variants in patients with atypical inflammatory diseases.

Authors:  Saori Kadowaki; Kunio Hashimoto; Toyoki Nishimura; Kenichi Kashimada; Tomonori Kadowaki; Norio Kawamoto; Kohsuke Imai; Satoshi Okada; Hirokazu Kanegane; Hidenori Ohnishi
Journal:  Arthritis Res Ther       Date:  2021-02-06       Impact factor: 5.156

Review 3.  A20 Haploinsufficiency in East Asia.

Authors:  Tomonori Kadowaki; Saori Kadowaki; Hidenori Ohnishi
Journal:  Front Immunol       Date:  2021-11-26       Impact factor: 7.561

Review 4.  Paediatric Behçet's Disease: A Comprehensive Review with an Emphasis on Monogenic Mimics.

Authors:  Ovgu Kul Cinar; Micol Romano; Ferhat Guzel; Paul A Brogan; Erkan Demirkaya
Journal:  J Clin Med       Date:  2022-02-26       Impact factor: 4.241

5.  Three Chinese pedigrees of A20 haploinsufficiency: clinical, cytokine and molecular characterization.

Authors:  Yi Tian; Bingxuan Wu; Linyi Peng; Jian Wang; Min Shen
Journal:  Front Immunol       Date:  2022-07-26       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.